Type II/III Runx2/Cbfal is required for tooth germ developmentKOBAYASHI, Ieyoshi; KIYOSHIMA, Tamotsu; WADA, Hiroko et al.Bone (New York, NY). 2006, Vol 38, Num 6, pp 836-844, issn 8756-3282, 9 p.Article

The inhibition of angiogenesis by antisense oligonucleotides to clusterinJACKSON, John K; GLEAVE, Martin E; GLEAVE, Jacqueline et al.Angiogenesis (London). 2005, Vol 8, Num 3, pp 229-238, issn 0969-6970, 10 p.Article

Local Dystrophin Restoration with Antisense Oligonucleotide PR0051VAN DEUTEKOM, Judith C; JANSON, Anneke A; DE KIMPE, Sjef J et al.The New England journal of medicine. 2007, Vol 357, Num 26, pp 2677-2686, issn 0028-4793, 10 p.Article

Local Dystrophin Restoration with Antisense Oligonucleotide PR0051PLAISIER, Emmanuelle; GRIBOUVAL, Olivier; DRACON, Michel et al.The New England journal of medicine. 2007, Vol 357, Num 26, pp 2687-2695, issn 0028-4793, 9 p.Article

An enema formulation of alicaforsen, an antisense inhibitor of intercellular adhesion molecule-1, in the treatment of chronic, unremitting pouchitisMINER, P. JR; WEDEL, M; BANE, B et al.Alimentary pharmacology & therapeutics. 2004, Vol 19, Num 3, pp 281-286, issn 0269-2813, 6 p.Article

Targeting oncogenic fusion genes in leukemias and lymphomas by RNA interferenceDAMM-WELK, Christine; FUCHS, Uta; WÖSSMANN, Wilhelm et al.Seminars in cancer biology. 2003, Vol 13, Num 4, pp 283-292, issn 1044-579X, 10 p.Article

Ror1-Ror2 COMPLEXES MODULATE SYNAPSE FORMATION IN HIPPOCAMPAL NEURONSPAGANONI, S; BERNSTEIN, J; FERREIR, A et al.Neuroscience. 2010, Vol 165, Num 4, pp 1261-1274, issn 0306-4522, 14 p.Article

Tumour cell delivery of antisense oligonucleotides by human serum albumin nanoparticlesWARTLICK, Heidrun; SPÄNKUCH-SCHMITT, Birgit; STREBHARDT, Klaus et al.Journal of controlled release. 2004, Vol 96, Num 3, pp 483-495, issn 0168-3659, 13 p.Article

Asialoganglioside enhances the efficiency of gene transfection mediated by cationic liposomes with a cationic cholesterol derivativeNOGUCHI, Shoichiro; HIRASHIMA, Naohide; NAKANISHI, Mamoru et al.Biological & pharmaceutical bulletin. 2003, Vol 26, Num 9, pp 1306-1310, issn 0918-6158, 5 p.Article

Prolactin releasing peptide (PrRP) : An endogenous regulator of cell growthSAMSON, Willis K; TAYLOR, Meghan M.Peptides (New York, NY. 1980). 2006, Vol 27, Num 5, pp 1099-1103, issn 0196-9781, 5 p.Article

Smart delivery of antisense oligonucleotides by anionic pH-sensitive liposomesFATTAL, Elias; COUVREUR, Patrick; DUBERNET, Catherine et al.Advanced drug delivery reviews. 2004, Vol 56, Num 7, pp 931-946, issn 0169-409X, 16 p.Article

Evaluation of an ¹⁸F-Labeled Oligonucleotide Probe Targeting p21^WAF1 Transcriptional Changes in Human Tumor CellsKOSLOWSKY, I; SHAHHOSSEINI, S; MIRZAYANS, R et al.Oncology research. 2011, Vol 19, Num 6, pp 265-274, issn 0965-0407, 10 p.Article

Piccolo knockdown-induced impairments of spatial learning and long-term potentiation in the hippocampal CA1 regionIBI, Daisuke; NITTA, Atsumi; ISHIGE, Kumiko et al.Neurochemistry international. 2010, Vol 56, Num 1, pp 77-83, issn 0197-0186, 7 p.Article

Mcl-1 overexpression in hepatocellular carcinoma : A potential target for antisense therapySIEGHART, Wolfgang; LOSERT, Doris; WACHECK, Volker et al.Journal of hepatology. 2006, Vol 44, Num 1, pp 151-157, issn 0168-8278, 7 p.Article

Increased 5-HT_2A receptor expression and function following central glucocorticoid receptor knockdown in vivoISLAM, Aminul; THOMPSON, Kevin S. J; AKHTAR, Saghir et al.European journal of pharmacology. 2004, Vol 502, Num 3, pp 213-220, issn 0014-2999, 8 p.Article

Megalencephalic leukoencephalopathy with subcortical cysts type 1 (MLC1) due to a homozygous deep intronic splicing mutation (c.895-226T>G) abrogated in vitro using an antisense morpholino oligonucleotideMANCINI, Cecilia; VAULA, Giovanna; SCALZITTI, Laura et al.Neurogenetics (Oxford. Print). 2012, Vol 13, Num 3, pp 205-214, issn 1364-6745, 10 p.Article

Lipoplex and peptide-based strategies for the delivery of steric-block oligonucleotidesRESINA, Sarah; ABES, Saïd; TUMER, John J et al.International journal of pharmaceutics. 2007, Vol 344, Num 1-2, pp 96-102, issn 0378-5173, 7 p.Conference Paper

In vitro and in vivo potentiating the cytotoxic effect of radiation on human U251 gliomas by the c-Met antisense oligodeoxynucleotidesCHU, Sheng-Hua; ZHU, Zhi-An; YUAN, Xian-Hou et al.Journal of neuro-oncology. 2006, Vol 80, Num 2, pp 143-149, issn 0167-594X, 7 p.Article

Real-time detection and efficacy of antisense oligonucleotides delivered by PAMAM dendrimers in living cellsMAKSIMENKO, A; HELIN, V; BERTRAND, J. R et al.STP pharma sciences. 2005, Vol 15, Num 1, pp 75-79, issn 1157-1489, 5 p.Article

Une classe de molécules attractives : les oligonucléotides thérapeutiquesFICHOU, Y; FEREC, C.Biofutur (Puteaux). 2007, Num 278, pp 36-39, issn 0294-3506, 4 p.Article

Displacement chromatography of anti-sense oligonucleotide and proteins using saccharin as a non-toxic displacerTUGCU, Nihal; DESHMUKH, Ranjit R; SANGHVI, Yogesh S et al.Reactive & functional polymers. 2003, Vol 54, Num 1-3, pp 37-47, issn 1381-5148, 11 p.Article

Locked nucleic acid (LNA) recognition of RNA: NMR solution structures of LNA :RNA hybridsPETERSEN, Michael; BONDENSGAARD, Kent; WENGEL, Jesper et al.Journal of the American Chemical Society. 2002, Vol 124, Num 21, pp 5974-5982, issn 0002-7863Article

Effect of hepatocyte growth factor on early human haemopoietic cell developmentRATAJCZAK, M. Z; MARLICZ, W; RATAJCZAK, J et al.British journal of haematology. 1997, Vol 99, Num 1, pp 228-236, issn 0007-1048Article

Antisense therapeutics: progress and prospectsTRAINOR, George L.Perspectives in drug discovery and design. 1996, Vol 4, issn 0928-2866, 93 p.Serial Issue

A Prospective Study in the Rational Design of Efficient Antisense Oligonucleotides for Exon Skipping in the DMD GeneALOYSIUS DWI PRAMONO, Zacharias; KENG BOON WEE; JIAN LI WANG et al.Human gene therapy. 2012, Vol 23, Num 7, pp 781-790, issn 1043-0342, 10 p.Article